The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors

Publication date

2025-01-11

Authors

Ríos Carrasco, MaríaISNI 0000000526330806
Lin, Ting-Hui
Zhu, Xueyong
García, Alba Gabarroca
Uslu, ElifISNI 0000000527796608
Liang, RuonanISNI 0000000524045489
Spruit, Cindy MariaISNI 000000050744332X
Richard, Mathilde
Boons, Geert-JanORCID 0000-0003-3111-5954ISNI 0000000120249047
Wilson, Ian A.

Editors

Advisors

Supervisors

Document Type

/dk/atira/pure/researchoutput/researchoutputtypes/workingpaper/preprint
Open Access logo

License

cc_by

Abstract

H5Nx viruses continue to wreak havoc in avian and mammalian species worldwide. The virus distinguishes itself by the ability to replicate to high titers and transmit efficiently in a wide variety of hosts in diverse climatic environments. Fortunately, transmission to and between humans is scarce. Yet, if such an event were to occur, it could spark a pandemic as humans are immunologically naïve to H5 viruses. A significant determinant of transmission to and between humans is the ability of the influenza A virus hemagglutinin (HA) protein to shift from an avian-type to a human-type receptor specificity. Here, we demonstrate that a 2016 2.3.4.4e virus HA can convert to human-type receptor binding via a single Q226L mutation, in contrast to a cleavage-modified 2016 2.3.4.4b virus HA. Using glycan arrays, x-ray structural analyses, tissue- and direct glycan binding, we show that L133aΔ and 227Q are vital for this phenotype. Thus, whereas the 2.3.4.4e virus HA only needs a single amino acid mutation, the modified 2.3.4.4b HA was not easily converted to human-type receptor specificity.

Keywords

SDG 3 - Good Health and Well-being

Citation

Carrasco, M R, Lin, T-H, Zhu, X, García, A G, Uslu, E, Liang, R, Spruit, C M, Richard, M, Boons, G-J, Wilson, I A & de Vries, R P 2025 'The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors' bioRxiv. https://doi.org/10.1101/2025.01.10.632119